Litcius/Paper detail

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops, James Izanec, Long-Long Gao, Christopher Gasink, Andrew Greenspan, Matthieu Allez, Silvio Danese, Stephen B. Hanauer, Vipul Jairath, Tanja Kuehbacher, James D. Lewis, Edward V. Loftus, Emese Mihály, Remo Panaccione, Ellen Scherl, О. Б. Щукина, William J. Sandborn, Anita Afzali, Lilia Aitova, Xavier Aldeguer i Mante, Matthieu Allez, I Altorjay, Federico Argüelles‐Arias, Alessandro Armuzzi, Monika Augustyn, Mauro Bafutto, Jésus Barrio, Jakob Begun, Clint Behrend, Geert Bezemer, Guillaume Bonnaud, Marija Branković, Ik Jang Byung, Xavier Calvet, Karen A. Chachu, Júlio Maria Fonseca Chebli, Jae Hee Cheon, Halina Cichoż‐Lach, Larry Clark, Fraser Cummings, Kunal Dalal, Silvio Danese, Nanne K.H. de Boer, Maria de Lourdes Abreu Ferrari, Étienne Désilets, Predrag Dugalić, George Duvall, Olga Fedorishina, Rafał Filip, Cristina Flores, Ronald Fogel, James Fon, Michael Frankel, Keith Friedenberg, Walter Fries, Vassileva Galina, Piotr Gietka, Rishi Goel, Peter Hasselblatt, Hans Herfarth, László Herszényi, Pieter Hindryckx, Frank Hoentjen, Carmen Horjus Talabur Horje, Satish Iduru, Peter M. Irving, Robert J. Isfort, Vipul Jairath, Michael Jones, Dilara Kalimullina, Jeffry Katz, Manreet Kaur, Sunil K Khurana, Joo Sung Kim, Young‐Ho Kim, D Kleczkowski, Slavko Knezevic, Aaron Knoll, Louis Y Korman, Iskren Kotzev, Andrey Kulyapin, Kang‐Moon Lee, Desirée Leemreis, Jarosław Leszczyszyn, Jimmy K. Limdi, Jack J. Lissauer, Edward V. Loftus, Ewa Małecka‐Panas, John K. Marshall, Emese Mihály, Lukáš Milan, Giovanni Monteleone, Aleksandar Nagorni, Danuta Owczarek, Nichole Palekar, Remo Panaccione, Young Soo Park, Sang Hyoung Park

2022The Lancet297 citationsDOIOpen Access PDF

Topics & Concepts

MedicineUstekinumabAdalimumabClinical endpointCrohn's diseaseInternal medicineClinical trialPopulationRandomized controlled trialIntention-to-treat analysisAdverse effectRandomizationMaintenance therapyDiseaseChemotherapyEnvironmental healthInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders